Jason Haas SEC EDGAR Filings (CIK 0001883821)

SEC EDGAR filings, ownership reports, and insider transactions for Jason Haas.

Business address
C/O Syros Pharmaceuticals, Inc., 35 Cambridgepark Drive, Cambridge, MA, 02140
Top holdings (ownership)
LGND
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Jason Haas has filed 18 SEC EDGAR filings since 13 Oct 2021

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing PRIMARY DOCUMENT 10 Jun 2025 06 Jun 2025 001-33093
4 Open Document Open Filing 4 20 Nov 2024 18 Nov 2024 001-37813
144 Open Document Open Filing 18 Nov 2024
144 Open Document Open Filing 18 Nov 2024
4 Open Document Open Filing 4 04 Nov 2024 31 Oct 2024 001-37813
4 Open Document Open Filing 4 12 Sep 2024 10 Sep 2024 001-37813
4 Open Document Open Filing PRIMARY DOCUMENT 18 Jun 2024 14 Jun 2024 001-33093
4 Open Document Open Filing 4 02 Apr 2024 31 Mar 2024 001-37813
4 Open Document Open Filing FORM 4 SUBMISSION 02 Nov 2023 31 Oct 2023 001-37813
4 Open Document Open Filing PRIMARY DOCUMENT 13 Jun 2023 09 Jun 2023 001-33093
4 Open Document Open Filing FORM 4 SUBMISSION 04 Apr 2023 31 Mar 2023 001-37813
4 Open Document Open Filing FORM 4 SUBMISSION 21 Feb 2023 16 Feb 2023 001-37813
4 Open Document Open Filing FORM 4 SUBMISSION 11 Oct 2022 06 Oct 2022 001-37813
4 Open Document Open Filing PRIMARY DOCUMENT 30 Jun 2022 29 Jun 2022 001-33093
3 Open Document Open Filing PRIMARY DOCUMENT 29 Jun 2022 29 Jun 2022 001-33093
4 Open Document Open Filing FORM 4 SUBMISSION 17 Feb 2022 15 Feb 2022 001-37813
4 Open Document Open Filing FORM 4 SUBMISSION 13 Oct 2021 12 Oct 2021 001-37813
3 Open Document Open Filing FORM 3 SUBMISSION 13 Oct 2021 12 Oct 2021 001-37813